Efficacy and Safety of Empagliflozin in NODAT

NCT03642184 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Difficult in enrolling suitable participants

Conditions

New Onset Diabetes After Transplant
Kidney Transplant; Complications

Interventions

DRUG: Empagliflozin
DRUG: Linagliptin

Sponsor

RenJi Hospital